-
Study aim
-
Increase of endometrium and fertilization in patients with thin endometrium using menstrual blood stem cells
-
Design
-
Clinical trial including a control group, two-arm parallel-group, randomized trial
-
Settings and conduct
-
The entire population will be selected according to the inclusion and exclusion criteria and all patients must sign the informed consent. The subjects will be randomly divided into intervention and control groups. Menstrual blood will be collected from the patients of the intervention group at days 1 or 2 of their menstruation cycle using menstrual cups. Stem cells will be isolated from collected menstrual blood and cultured in vitro. Cultured cells will be evaluated for phenotyping and non-contamination. Autologous cells will be administered to the endometrium in the Avicenna Infertility Clinic. Whole blood will be collected from the control group and PRP will be injected into their endometrium.
-
Participants/Inclusion and exclusion criteria
-
married females, history of infertility, no responding to routine treatment, endometrium thickness bellow 7 mm on ovulation time, having at least 2 high-quality embryos in freeze cycle, endometrium tissue pattern of 3 and 4 based on Appelbaum classification
exclusion criteria; thyroid dysfunction, Immunosystem diseases, history of cancer, chemotherapy, and radiotherapy, hepatitis C, B, and HIV infection, endometriosis, diabetes, liver and electrolyte disorders
-
Intervention groups
-
Intervention group: are treated by autologous stem cell infusion
Control group: are treated by injection of PRP into their endometrium
-
Main outcome variables
-
Endometrium thickness, uterine arterial blood flow, presence of blood supply in zone 3 of the endometrium, improvement of endometrium patterns, spontaneous pregnancy, clinical pregnancy, Implantation rate, live birth rate